Asset Management One Co., Ltd. Sarepta Therapeutics, Inc. Transaction History

Asset Management One Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$69.38 - $86.75 $2.35 Million - $2.94 Million	-33,918 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $97,971 - $229,096	-1,356 Reduced 3.84%	33,918 $2.53 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $90,654 - $129,050	-722 Reduced 2.01%	35,274 $6.06 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $113,518 - $153,899	-893 Reduced 2.42%	35,996 $5.06 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $52,266 - $96,495	-562 Reduced 1.5%	36,889 $5.92 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $21,665 - $34,621	-263 Reduced 0.7%	37,451 $3.66 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $2.75 Million - $5.92 Million	37,714 New	37,714 $2.84 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.